Exploring Als Biomarkers In Drug Development
Let's dive into the details surrounding Als Biomarkers In Drug Development.
- PUBLISHED 03/26/2020
- ALS drug development
- Presenters and Panelists: Jiri Aubrecht, Pharm D, PhD; Tanja Zabka, DVM, DACVP, DSP; Warren Glaab, PhD; Gary Friedman, ...
- ALS
- Jeffrey Siegel, MD Office Director Office of
In-Depth Information on Als Biomarkers In Drug Development
Xtalks webinar presented by Atlantic Research Group (ARG) featuring Ignazio Di Giovanna, PhD, Vice-President, Europe, ARG, ... Recording of the virtual Early What will it take to develop reliable Jinsy Andrews, director of neuromuscular
Dr.James Berry presents an insightful seminar on how Technology can hasten
That wraps up our extensive overview of Als Biomarkers In Drug Development.
